[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.111.118. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
November 1986

Improved Survival in Squamous Esophageal CancerPreoperative Chemotherapy and Irradiation

Author Affiliations

From the Departments of Surgery (Drs Popp and Reising), Medicine (Drs Hawley, Bongiovanni, Weesner, and Martelo), Biostatistics (Dr Moomaw), and Radiology (Dr Aron), University of Cincinnati Medical Center and Cincinnati Veterans Administration Medical Center.

Arch Surg. 1986;121(11):1330-1335. doi:10.1001/archsurg.1986.01400110122021
Abstract

• Initial trials of irradiation and chemotherapy followed by operation for squamous carcinoma of the esophagus have produced encouraging results. Over the past three years, with palliative and curative intent, we have treated 27 unselected patients initially with two courses of chemotherapy (fluorouracil and either cisplatin, mitomycin, or cisplatin and vincristine sulfate) given 29 days apart and 3000 rad (30 Gy) of radiation. Ten patients have then undergone esophageal resection and two patients have undergone esophageal bypass. Results are compared with those of 70 unselected historical control patients treated since 1979. Survival at 30 months was significantly improved for multimodality-treated patients (21.4%±10.1%, mean±SEM) when compared with historical control patients (4.8%±2.7%). Twenty-four percent of multimodality-treated patients had complete remission of all tumor. These data indicate that overall therapy for carcinoma of the esophagus has been improved in our institutions.

(Arch Surg 1986;121:1330-1335)

References
1.
American Cancer Society:  Cancer statistics, 1986 . CA 1986;36:9-25.
2.
Guernsey JM, Doggett RLS II, Mason GR, et al:  Combined treatment of the esophagus . Am J Surg 1969;117:157-161.Article
3.
Kelsen D, Bains M, Hilarias B, et al:  Combined-modality therapy of esophageal cancer . Semin Oncol 1984;11:169-177.
4.
Kelsen DP, Hilarias B, Coohley C, et al:  Cis-platinum, vindesine, and bleomycin chemotherapy of local, regional and advanced esophageal cancer . Am J Med 1983;75:645-652.Article
5.
Shields TW, Rosen ST, Hellerstein SM, et al:  Multimodality approach to treatment of carcinoma of the esophagus . Arch Surg 1984;119:558-562.Article
6.
Leichman L, Steiger ZM, Seydel HG, et al:  Preoperative chemotherapy and radiation therapy in patients with cancer of the esophagus: A potentially curative approach . J Clin Oncol 1984;2:75-79.
7.
Leichman L, Seydel HG, Steiger ZM, et al:  Preoperative adjuvant therapy for squamous cell cancer of the esophagus: SWOG and RTOG clinical trials , abstracted. Proc Am Soc Clin Oncology 1984;3:147.
8.
Orringer MB, Sloan H:  Esophagectomy without thoracotomy . Thorac Cardiovasc Surg 1978;76:643-654.
9.
Orringer MB, Sloan H:  Substernal gastric bypass of the excluded thoracic esophagus for palliation of esophageal carcinoma . J Thorac Cardiovasc Surg 1975;70:836-851.
10.
Behrs OH, Myers MH (eds): Manual for Staging of Cancer , ed 2. Philadelphia, JB Lippincott Co, 1983, pp 61-66.
11.
Popp MB, Wagner S, Brito OJ:  Host and tumor responses to increasing levels of intravenous nutritional support . Surgery 1983;94:300-308.
12.
Brennan MF:  Total parenteral nutrition in the cancer patient . N Engl J Med 1981;305:375-382.Article
×